Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity (Q44959008)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

Syed M Faisal

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

WeiWei Yan

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sean P McDonough

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Yung-Fu Chang

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

0 references

publication date

18 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

378-387

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Leptospirosis: a zoonotic disease of global importance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Comparison of the efficacy of three commercial bacterins in preventing canine leptospirosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

[Efficacy of Spirolept vaccine against human leptospirosis as estimated by passive protection of laboratory rodents]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Leptospira interrogans activation of human peripheral blood mononuclear cells: preferential expansion of TCR gamma delta+ T cells vs TCR alpha beta+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Activation of bovine peripheral blood gammadelta T cells for cell division and IFN-gamma production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Immunogenicity of the recombinant leptospiral putative outer membrane proteins as vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Expression of leptospiral immunoglobulin-like protein by Leptospira interrogans and evaluation of its diagnostic potential in a kinetic ELISA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Cloning and molecular characterization of an immunogenic LigA protein of Leptospira interrogans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Genome sequence and comparative analysis of the solvent-producing bacterium Clostridium acetobutylicum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Leptospiral immunoglobulin-like proteins elicit protective immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Recombinant subunit vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Adjuvants--a balance between toxicity and adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Isolation and quantification of Quillaja saponaria Molina saponins and lipids in iscom-matrix and iscoms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Immunogenicity of IRIV- versus alum-adjuvanted diphtheria and tetanus toxoid vaccines in influenza primed mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Immunological adjuvants: a role for liposomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Improving protein therapeutics with sustained-release formulations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Biodegradable microspheres in drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Biodegradable microspheres as a vaccine delivery system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Controlled release microparticles for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Preparation of liposomes containing factor VIII for oral treatment of haemophilia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Controlled-release vaccines--biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Protein instability in poly(lactic-co-glycolic acid) microparticles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

A domain of the Leptospira LigB contributes to high affinity binding of fibronectin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

The C-terminal variable domain of LigB from Leptospira mediates binding to fibronectin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Calcium binds to leptospiral immunoglobulin-like protein, LigB, and modulates fibronectin binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Rapid translocation of polarized MDCK cell monolayers by Leptospira interrogans, an invasive but nonintracellular pathogen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.089

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2008.10.089

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44959008&oldid=2059523210"